We are live on ! Find out more
GCM

Graham Capital Management Portfolio holdings

AUM $4.14B
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
-1.59%
1 Year Est. Return
+17.82%
3 Year Est. Return
+41.13%
5 Year Est. Return
+43.39%
10 Year Est. Return
+274.46%
AUM
$4.6B
AUM Growth
-$711M
Cap. Flow
-$1.38B
Cap. Flow %
-30.11%
Top 10 Hldgs %
50.61%
Holding
1,450
New
426
Increased
279
Reduced
266
Closed
448

Top Buys

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$33.1M
2
HES
Hess
HES
+$17.4M
3
KO icon
Coca-Cola
KO
+$15.5M
4
TMO icon
Thermo Fisher Scientific
TMO
+$14.4M
5
CMS icon
CMS Energy
CMS
+$13.4M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$26.3M
2
MSFT icon
Microsoft
MSFT
+$25.4M
3
DG icon
Dollar General
DG
+$23.9M
4
UBER icon
Uber
UBER
+$20.4M
5
JPM icon
JPMorgan Chase
JPM
+$18.9M

Sector Composition

Rank Sector Weight
1 Technology 6.67%
2 Industrials 4.67%
3 Financials 4.38%
4 Consumer Discretionary 3.19%
5 Healthcare 3.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNDT icon
951
Conduent
CNDT
$264M
$63.7K ﹤0.01%
+19,528
New +$66.4K
ALEC icon
952
Alector
ALEC
$199M
$61.9K ﹤0.01%
+13,639
New +$70.2K
CHRS icon
953
Coherus Oncology
CHRS
$196M
$61.4K ﹤0.01%
+35,481
New +$71.4K
KOPN icon
954
Kopin
KOPN
$791M
$61.2K ﹤0.01%
+72,879
New +$71K
UNIT
955
Uniti Group
UNIT
$2.32B
$60K ﹤0.01%
+20,547
New +$86.1K
TALK icon
956
Talkspace
TALK
$874M
$59.2K ﹤0.01%
25,740
-7,213
-22% -$20.7K
AKBA icon
957
Akebia Therapeutics
AKBA
$252M
$58.8K ﹤0.01%
57,624
+28,838
+100% +$35.6K
NOTV
958
DELISTED
Inotiv
NOTV
$56.8K ﹤0.01%
+34,212
New +$126K
TNYA icon
959
Tenaya Therapeutics
TNYA
$163M
$50.3K ﹤0.01%
+16,227
New +$67K
NXDR
960
Nextdoor Holdings
NXDR
$986M
$49.2K ﹤0.01%
+17,689
New +$40.9K
ZNTL icon
961
Zentalis Pharmaceuticals
ZNTL
$302M
$46.9K ﹤0.01%
+11,465
New +$128K
ME
962
DELISTED
23andMe Holding Co
ME
$46.8K ﹤0.01%
5,978
+1,427
+31% +$13.7K
AMPS
963
DELISTED
Altus Power
AMPS
$46.8K ﹤0.01%
+11,930
New +$49.6K
ERAS icon
964
Erasca
ERAS
$6.39B
$41.1K ﹤0.01%
17,414
-18,996
-52% -$41K
SES icon
965
SES AI
SES
$208M
$40.9K ﹤0.01%
32,733
+3,564
+12% +$4.84K
SPWH icon
966
Sportsman's Warehouse
SPWH
$46M
$38.2K ﹤0.01%
15,838
+3,787
+31% +$12K
FATE icon
967
Fate Therapeutics
FATE
$326M
$37.9K ﹤0.01%
+11,565
New +$50.6K
BW icon
968
Babcock & Wilcox
BW
$1.39B
$37.4K ﹤0.01%
+25,782
New +$31K
AMRN
969
Amarin Corp
AMRN
$303M
$35.8K ﹤0.01%
2,602
+154
+6% +$2.65K
NKTR icon
970
Nektar Therapeutics
NKTR
$2.58B
$33.9K ﹤0.01%
+1,823
New +$38.4K
ALLK
971
DELISTED
Allakos
ALLK
$33.3K ﹤0.01%
33,270
-4,989
-13% -$5.93K
PSTX
972
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$32.1K ﹤0.01%
+11,004
New +$30.1K
FSP
973
Franklin Street Properties
FSP
$46.8M
$29.5K ﹤0.01%
19,292
+5,062
+36% +$9.53K
TSE
974
DELISTED
Trinseo
TSE
$28.5K ﹤0.01%
12,349
-23,116
-65% -$71.9K
CTEV
975
Claritev Corp
CTEV
$556M
$28.3K ﹤0.01%
1,824
+473
+35% +$11.3K
37 38
39
40 41

Similar funds

SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Graham Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Graham Capital Management held 1,450 positions worth $4.6B, down 13% from $5.31B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Graham Capital Management withdrew a net $1.38B in Q2 2024, closing 448 positions and reducing 266 holdings. Its most notable exit was JPMorgan Chase, an estimated $18.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.7% of assets, down from 7.6% a quarter earlier, followed by Industrials and Financials.

Against the trend, Graham Capital Management opened a new position in Hess worth $16.8M.

  • Graham Capital Management's largest Q2 2024 buy was Hess: 113,741 shares worth $16.8M.
  • Graham Capital Management added most to Strategy Inc in Q2 2024, an estimated $33.1M increase.
  • Graham Capital Management's biggest Q2 2024 reduction was Amazon, cutting an estimated $26.3M.
  • Graham Capital Management fully exited JPMorgan Chase in Q2 2024, selling an estimated $18.9M.
  • Graham Capital Management's ten largest holdings make up 51% of its $4.6B portfolio in Q2 2024.
  • Graham Capital Management opened 426 new positions and closed 448 in Q2 2024.
  • Graham Capital Management's portfolio value fell 13% quarter-over-quarter to $4.6B.

Based on Graham Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.